stage IV adult diffuse small cleaved cell lymphoma
Showing 26 - 50 of >10,000
Ann Arbor Stage III Grade 1 Follicular Lymphoma, Ann Arbor Stage III Grade 2 Follicular Lymphoma, Ann Arbor Stage III Indolent
Completed
- Ann Arbor Stage III Grade 1 Follicular Lymphoma
- +9 more
- Lenalidomide
- Rituximab
-
Houston, TexasM D Anderson Cancer Center
Sep 28, 2021
Advanced Lung Non-Small Cell Carcinoma, Stage IIIB Lung Cancer AJCC v8, Stage IIIC Lung Cancer AJCC v8 Trial (drug, procedure,
Not yet recruiting
- Advanced Lung Non-Small Cell Carcinoma
- +3 more
- Carboplatin
- +9 more
- (no location specified)
Oct 21, 2023
Contiguous Stage II Small Lymphocytic Lymphoma, Noncontiguous Stage II Small Lymphocytic Lymphoma, Prolymphocytic Leukemia Trial
Active, not recruiting
- Contiguous Stage II Small Lymphocytic Lymphoma
- +11 more
- MOR00208
- +2 more
-
Columbus, OhioThe Ohio State University Comprehensive Cancer Center
Feb 24, 2022
Prolymphocytic Leukemia, Recurrent Adult Diffuse Large Cell Lymphoma, Recurrent Mantle Cell Lymphoma Trial in Columbus, Salt
Active, not recruiting
- Prolymphocytic Leukemia
- +4 more
- Selinexor
- +3 more
-
Columbus, Ohio
- +1 more
Apr 29, 2022
Ann Arbor Stage III DLBCL, Ann Arbor Stage IIX (Bulky) DLBCL, Ann Arbor Stage IV DLBCL Trial in United States (drug, other,
Suspended
- Ann Arbor Stage III Diffuse Large B-Cell Lymphoma
- +20 more
- Cyclophosphamide
- +6 more
-
Tucson, Arizona
- +110 more
Jan 31, 2023
Chronic Lymphocytic Leukemia; Small Lymphocytic Lymphoma; Diffuse Large B-cell Lymphoma; Acute Lymphoblastic Leukemia Trial in
Recruiting
- Chronic Lymphocytic Leukemia; Small Lymphocytic Lymphoma; Diffuse Large B-cell Lymphoma; Acute Lymphoblastic Leukemia
- YTB323 and ibrutinib
- YTB323 single agent
-
Tampa, Florida
- +20 more
Feb 24, 2022
Contiguous Stage II Adult Lymphoblastic Lymphoma, Noncontiguous Stage II Adult Lymphoblastic Lymphoma, Stage I Adult
Completed
- Contiguous Stage II Adult Lymphoblastic Lymphoma
- +5 more
- carfilzomib
- +10 more
-
Sacramento, CaliforniaUniversity of California Davis
Mar 8, 2022
AIDS-Related Plasmablastic Lymphoma, AIDS-Related Primary Effusion Lymphoma, Ann Arbor Stage I DLBCL Trial in United States
Completed
- AIDS-Related Plasmablastic Lymphoma
- +15 more
- Cyclophosphamide
- +8 more
-
Montgomery, Alabama
- +34 more
Feb 23, 2022
Acute Leukemia, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia Trial in Seattle (procedure, drug, biological, radiation)
Recruiting
- Acute Leukemia
- +18 more
- Allogeneic Hematopoietic Stem Cell Transplantation
- +8 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Oct 26, 2022
Non Small Cell Lung Cancer, Brain Metastases, Adult, Lung Cancer Trial in Spain (Ipilimumab, Nivolumab, Carboplatin)
Recruiting
- Non Small Cell Lung Cancer
- +2 more
- Ipilimumab
- +5 more
-
Badalona, Barcelona, Spain
- +17 more
Jun 1, 2022
Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL) Trial in Japan (Venetoclax, Ibrutinib, Obinutuzumab)
Recruiting
- Chronic Lymphocytic Leukemia (CLL)
- Small Lymphocytic Lymphoma (SLL)
- Venetoclax
- +2 more
-
Nagoya-shi, Aichi, Japan
- +19 more
Jan 25, 2023
Brain and CNS Tumors, Chronic Myeloproliferative Disorders, Leukemia Trial in Detroit (3'-deoxy-3'-[18F]fluorothymidine)
Recruiting
- Brain and Central Nervous System Tumors
- +8 more
- 3'-deoxy-3'-[18F]fluorothymidine
-
Detroit, MichiganBarbara Ann Karmanos Cancer Institute
Mar 30, 2022
Lymphoma Trial in Worldwide (immunoscintigraphy, technetium Tc 99m epratuzumab)
Unknown status
- Lymphoma
- immunoscintigraphy
- technetium Tc 99m epratuzumab
-
Los Angeles, California
- +7 more
Aug 12, 2021
AIDS-Related Non-Hodgkin Lymphoma, Classic Hodgkin Lymphoma, Clinical Stage III Cutaneous Melanoma AJCC v8 Trial in United
Recruiting
- AIDS-Related Non-Hodgkin Lymphoma
- +29 more
- Laboratory Biomarker Analysis
- Pembrolizumab
-
Birmingham, Alabama
- +12 more
Aug 4, 2022
Safety of Zepzelca in Adult Extensive Stage Small Cell Lung
Recruiting
- Extensive-stage Small-cell Lung Cancer
-
Huntsville, Alabama
- +36 more
Jul 25, 2022
Acute Leukemia, Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia Trial in Minneapolis (HSCT with TBI Regimen, HSCT with
Recruiting
- Acute Leukemia
- +27 more
- HSCT with TBI Regimen
- HSCT with Non-TBI Regimen
-
Minneapolis, MinnesotaMasonic Cancer Center at University of Minnesota
Apr 12, 2022
Lymphoma Trial in Worldwide (immunoscintigraphy, technetium Tc 99m epratuzumab)
Unknown status
- Lymphoma
- immunoscintigraphy
- technetium Tc 99m epratuzumab
-
Los Angeles, California
- +7 more
Aug 12, 2021
Acute Myeloid Leukemia (AML), Acute Lymphocytic Leukemia in Relapse, Burkitt's Lymphoma Stage III Trial in Hartford, Calgary,
Recruiting
- Acute Myeloid Leukemia (AML)
- +4 more
- Individualized Yoga Intervention Group
- iPad Activity Control Group
-
Hartford, Connecticut
- +2 more
Sep 16, 2021
Tissue, Blood, and Body Fluid Sample Collection From Hematologic
Recruiting
- Chronic Myeloproliferative Disorders
- +7 more
- biologic sample preservation procedure
- cytology specimen collection procedure
-
Chapel Hill, North CarolinaLineberger Comprehensive Cancer Center at University of North Ca
Oct 14, 2021
Ann Arbor Stage II Non-Hodgkin Lymphoma, Ann Arbor Stage III Non-Hodgkin Lymphoma, Ann Arbor Stage IV Non-Hodgkin Lymphoma Trial
Active, not recruiting
- Ann Arbor Stage II Non-Hodgkin Lymphoma
- +2 more
- Cyclophosphamide
- +6 more
-
Mobile, Alabama
- +189 more
Jan 28, 2023
Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma Trial in
Completed
- Adult Nasal Type Extranodal NK/T-cell Lymphoma
- +35 more
- Akt inhibitor MK2206
- laboratory biomarker analysis
-
Houston, TexasM D Anderson Cancer Center
Oct 14, 2020
Brain and CNS Tumors, Chronic Myeloproliferative Disorders, Leukemia Trial in Chicago (Pemetrexed)
Completed
- Brain and Central Nervous System Tumors
- +10 more
-
Chicago, IllinoisRobert H. Lurie Comprehensive Cancer Center at Northwestern Univ
Sep 3, 2021
Collecting and Storing Blood Samples From Patients With Cancer
Withdrawn
- Brain and Central Nervous System Tumors
- +10 more
- (no location specified)
Sep 20, 2021
Lymphoma, Non-Hodgkin, Advanced Stage Diffuse Large B-Cell Non-Hodgkin's Lymphoma Trial in Vancouver (Cyclophosphamide,
Active, not recruiting
- Lymphoma, Non-Hodgkin
- Advanced Stage Diffuse Large B-Cell Non-Hodgkin's Lymphoma
- Cyclophosphamide
- +14 more
-
Vancouver, British Columbia, CanadaBC Cancer Agency
Jul 20, 2021